- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
GHB use down overall
By UCSF School of Pharmacy Editorial Staff / Thu Jan 5, 2006
Reports to the California Poison Control System of the use of the drug gamma hydroxybutate (GHB) have declined overall from 1999 to 2003. These findings were reported on December 29, 2005 in the Annals of Emergency Medicine. The lead study author is Ilene Anderson, PharmD, UCSF School of Pharmacy faculty member and clinical pharmacist with the California Poison Control System, which is administered by the UCSF School of Pharmacy.
Tags
Category:
Sites:
School of Pharmacy, PharmD Degree Program
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
Related news
- California Poison Control System receives funding through June 2010
- Governor eliminates California’s Poison Control Service
- California Poison Control System pharmacist warns pot alternative harmful
- California Poison Control System layoff notices predicted
- Fate of California Poison Control System watched nationwide
Recent news
Share your news
Faculty and staff: We want to hear about the work that you are engaged in, such as honors and awards received, publications, and events featuring you.